Success Metrics

Clinical Success Rate
70.6%

Based on 12 completed trials

Completion Rate
71%(12/17)
Active Trials
1(4%)
Results Posted
25%(3 trials)
Terminated
5(21%)

Phase Distribution

Ph phase_4
9
38%
Ph phase_2
7
29%
Ph not_applicable
1
4%
Ph phase_1
2
8%
Ph phase_3
4
17%

Phase Distribution

2

Early Stage

7

Mid Stage

13

Late Stage

Phase Distribution23 total trials
Phase 1Safety & dosage
2(8.7%)
Phase 2Efficacy & side effects
7(30.4%)
Phase 3Large-scale testing
4(17.4%)
Phase 4Post-market surveillance
9(39.1%)
N/ANon-phased studies
1(4.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

63.2%

12 of 19 finished

Non-Completion Rate

36.8%

7 ended early

Currently Active

1

trials recruiting

Total Trials

24

all time

Status Distribution
Active(1)
Completed(12)
Terminated(7)
Other(4)

Detailed Status

Completed12
Terminated5
unknown4
Withdrawn2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
24
Active
1
Success Rate
70.6%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (8.7%)
Phase 27 (30.4%)
Phase 34 (17.4%)
Phase 49 (39.1%)
N/A1 (4.3%)

Trials by Status

unknown417%
withdrawn28%
completed1250%
recruiting14%
terminated521%

Recent Activity

Clinical Trials (24)

Showing 20 of 24 trialsScroll for more
NCT03295734Phase 2

ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension

Completed
NCT02085265Phase 2

Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients

Terminated
NCT06341101Phase 4

Timely Recovery After Subclinical Heart Failure

Recruiting
NCT04591808Phase 3

Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia

Terminated
NCT05535595Phase 4

Precision Treatment With Angiotensin Converting Enzyme Inhibitor

Completed
NCT02308202Phase 1

DOXAZOSIN FOR PTSD

Completed
NCT01062451Phase 1

An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence

Completed
NCT00915928Not Applicable

Chronic Subdural Hematoma - Reduction of Recurrence by Treatment With Angiotensin Converting Enzyme Inhibitors

Terminated
NCT04342351Phase 4

Early Treatment of ARNI on Myocardial Remodeling and Progress

Unknown
NCT00461903Phase 3

Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential Hypertension

Completed
NCT02651415Phase 2

Phase II Study of Perindopril and Regorafenib in mCRC

Completed
NCT03921736Phase 4

Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.

Completed
NCT02449811

RAS Peptide Profiles in Patients With Arterial Hypertension

Completed
NCT00202592Phase 2

S90652 in Paediatric Hypertension

Completed
NCT00202553Phase 2

S90652 in Paediatric Hypertension

Completed
NCT02777489Phase 2

Influence of Carboxypeptidase D (CPD) Gene on Body Weight and Fat Mass Reduction by Perindopril in Obese Subjects

Terminated
NCT02729441Phase 3

Perindopril vs Ramipril for Persistence in MAU Reduction Study

Completed
NCT01583114Phase 3

PREclinical Mutation CARriers From Families With DIlated Cardiomyopathy and ACE Inhibitors

Terminated
NCT01819441Phase 4

Stratification of Blood Pressure Control Against Progress of Cerebral Small Vessel Diseases in Poststroke Patients

Unknown
NCT01948232Phase 2

Pilot Study of Perindopril in Childhood Cancer Survivors

Withdrawn

Drug Details

Intervention Type
DRUG
Total Trials
24